/PRNewswire/ Galderma, the emerging pure-play dermatology category leader, today announced a new campaign to provide education and support for breast cancer.
/PRNewswire/ Galderma announced today that the U.S. Food and Drug Administration (FDA) has approved Sculptra® (injectable poly-L-lactic acid (PLLA-SCA)) for.
KUALA LUMPUR, Malaysia, March 30, 2023 /PRNewswire/ Galderma, the pure-play dermatology company, announces a change in its marketing operations to better serve the healthcare community in Malaysia. Through this development, the company has established its own team of marketing personnel, product specialists and brand representatives to engage with healthcare professionals and institutions directly. The transfer of commercial activities.
/PRNewswire/ Galderma, the world s largest independent dermatology company, today announces the launch of ALASTIN Skincare® A-LUMINATE BRIGHTENING SERUM®..